Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02632266 · ClinicalTrials.gov registry record · Phase 4
Effect of Extensively Hydrolyzed Liquid Human Milk Fortifier on Growth and Tolerance in Moderately Premature Infants
A Phase 4 study, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT02632266 is a Phase 4 study that has completed, run by University of Kansas Medical Center. The registered enrollment target is 40 participants.
The verdict
NCT02632266, a Phase 4 study, has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is for the researchers to examine the safety and efficacy of liquid human milk fortifier (HMF) in moderately preterm infants compared to powdered human milk fortifier.
Interventions
- DIETARY_SUPPLEMENT Powder HMF
- DIETARY_SUPPLEMENT Liquid HMF
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2015-07 |
| Est. Completion | 2019-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02632266
The ClinicalTrials.gov registry entry for NCT02632266 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Powder HMF is the first listed.
NCT02632266 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02632266 about?
NCT02632266 is a clinical study titled "Effect of Extensively Hydrolyzed Liquid Human Milk Fortifier on Growth and Tolerance in Moderately Premature Infants". The purpose of this study is for the researchers to examine the safety and efficacy of liquid human milk fortifier (HMF) in moderately preterm infants compared to powdered human milk fortifier.
What is the current status of trial NCT02632266?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2015-07. Estimated completion is 2019-05.
What interventions are being tested in trial NCT02632266?
The interventions under investigation include: Powder HMF (DIETARY_SUPPLEMENT), Liquid HMF (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02632266?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.